California Public Employees Retirement System’s Quince Therapeutics QNCX Stock Holding History

California Public Employees Retirement System’s Portfolio QNCX Stock Details QNCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-160	Closed	-$1.15M	–	2604
2021 Q1	$1.15M	Sell	160 -15	-9%	-$108K	﹤0.01%	2394
2020 Q4	$971K	Sell	175 -3	-2%	-$26.6K	﹤0.01%	2492
2020 Q3	$1.78M	Buy	178 +4	+2%	+$36.4K	﹤0.01%	1883
2020 Q2	$1.61M	Buy	174 +52	+43%	+$476K	﹤0.01%	1917
2020 Q1	$1.11M	Buy	+122	New	+$1.2M	﹤0.01%	1947

Other funds holding QNCX

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PHAM

Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return

California Public Employees Retirement System's QNCX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Quince Therapeutics (QNCX) in Q2 2021, closing a stake of 160 shares — an estimated $1.15M sold.

California Public Employees Retirement System first reported a position in QNCX in Q1 2020 and held it in 5 quarters. The position peaked at $1.78M in Q3 2020. 100 funds tracked by Wall St. Rank hold QNCX as of Q2 2021.

California Public Employees Retirement System reported no remaining Quince Therapeutics position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 160 Quince Therapeutics shares in Q2 2021, an estimated $1.15M.
California Public Employees Retirement System first reported a position in Quince Therapeutics in Q1 2020 and held it in 5 quarters.
California Public Employees Retirement System's Quince Therapeutics position peaked at $1.78M in Q3 2020.
100 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.